Antitumor effects of α-bisabolol against pancreatic cancer

73Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the present study, we investigated whether α-bisabolol, a sesquiterpene alcohol present in essential oils derived from a variety of plants, has antitumor effects against pancreatic cancer. α-Bisabolol induced a decrease in cell proliferation and viability in pancreatic cancer cell lines (KLM1, KP4, Panc1, MIA Paca2), but not in pancreatic epithelial cells (ACBRI515). α-Bisabolol treatment induced apoptosis and suppressed Akt activation in pancreatic cancer cell lines. Furthermore, α-bisabolol treatment induced the overexpression of early growth response-1 (EGR1), whereas EGR1 siRNA decreased the α-bisabolol-induced cell death of KLM1 cells. Tumor growth in both subcutaneous and peritoneal xenograft nude mouse models was significantly inhibited by intragastric administration of 1000mg/kg of α-bisabolol, once a week for three weeks. The results indicate that α-bisabolol could be a novel therapeutic option for the treatment of pancreatic cancer. © 2011 Japanese Cancer Association.

Cite

CITATION STYLE

APA

Seki, T., Kokuryo, T., Yokoyama, Y., Suzuki, H., Itatsu, K., Nakagawa, A., … Nagino, M. (2011). Antitumor effects of α-bisabolol against pancreatic cancer. Cancer Science, 102(12), 2199–2205. https://doi.org/10.1111/j.1349-7006.2011.02082.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free